<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Thursday April 23rd 2020 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2020-04-23" ></link>
<id>urn:uuid:aeb583bc-b464-302b-f17f-178b416eaac3</id>
<updated>2026-04-24T13:35:07-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABT: GINASCOL JOHN F (VP) Exercised 63,200 Options (OE) of ABBOTT LABORATORIES for $38.40 on 4/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3998211" ></link>
<id>urn:uuid:e6ce3554-3820-9dfd-2c6b-fad028073739</id>
<updated>2020-04-23T21:41:18-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $91.34. Mkt Cap:158.7B. 10D Vol: 14.4mm]]></summary>
</entry>
<entry>
<title>ABT: CAPEK JOHN M (VP) Exercised 50,100 Options (OE) of ABBOTT LABORATORIES for $22.39 on 4/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3998209" ></link>
<id>urn:uuid:4170e8d0-e874-2335-986a-7a67f486740f</id>
<updated>2020-04-23T21:34:24-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $91.34. Mkt Cap:158.7B. 10D Vol: 14.4mm]]></summary>
</entry>
<entry>
<title>ABT: SCOGGINS CHRISTOPHER J (VP) Sold (AS) 414 Shares of ABBOTT LABORATORIES for $96.10 on 4/21</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3998207" ></link>
<id>urn:uuid:978fe97b-0065-4a40-17bb-5ff19daf090c</id>
<updated>2020-04-23T21:28:21-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $91.34. Mkt Cap:158.7B. 10D Vol: 14.4mm]]></summary>
</entry>
<entry>
<title>ABT: FUNCK ROBERT E (VP,CFO) Exercised 36,700 Options (OE) of ABBOTT LABORATORIES for $34.94-$39.12 on 4/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3998205" ></link>
<id>urn:uuid:ee61de0c-c092-d601-cab8-356e35537113</id>
<updated>2020-04-23T21:27:16-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $91.34. Mkt Cap:158.7B. 10D Vol: 14.4mm]]></summary>
</entry>
<entry>
<title>ABT: CONTRERAS JAIME (VP) Exercised 108,412 Options (OE) of ABBOTT LABORATORIES for $44.40-$75.90 on 4/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/abt/abbott-laboratories/id-3998203" ></link>
<id>urn:uuid:1483b2da-98ca-59e2-51ac-5d4900ed527c</id>
<updated>2020-04-23T21:26:08-04:00</updated>
<summary type="html" ><![CDATA[ABBOTT LABORATORIES (ABT). Recent Price: $91.34. Mkt Cap:158.7B. 10D Vol: 14.4mm]]></summary>
</entry>
<entry>
<title>ACN: SHOOK ELLYN (HR) Sold (AS) 1,251 Shares of ACCENTURE PLC for $175.00 on 4/23</title>
<link href="http://www.insiderinsights.com/company/acn/accenture-plc/id-3998120" ></link>
<id>urn:uuid:50bfed9c-fe17-57c6-6b54-9bfb1a6d9c6e</id>
<updated>2020-04-23T17:54:23-04:00</updated>
<summary type="html" ><![CDATA[ACCENTURE PLC (ACN). Recent Price: $174.67. Mkt Cap:107.5B. 10D Vol: 5.3mm]]></summary>
</entry>
</feed>